Enliven Therapeutics, Inc. (ELVN): 8-K filed Aug 5, 2026

Form type

8-K

Filing date

Aug 5, 2026

Accession number

0001193125-26-335101

Filer

Enliven Therapeutics, Inc. (CIK 1672619)